Dr. Munster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-885-3631Fax+1 415-353-7021
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
- Indiana University School of MedicineResidency, Internal Medicine, 1993 - 1996
- University of Bern Faculty of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 2008 - 2026
- FL State Medical License 2001 - 2010
- NY State Medical License 2000 - 2003
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.Christopher T Chen, Vishesh Khanna, Shivaani Kummar, Raghad M Abdul-Karim, David Sommerhalder
Cancer Research Communications. 2024-09-01 - Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky
JCO Precision Oncology. 2024-06-01 - 1 citationsFirst-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas B Karasic, Oxana V Crysler
Cancer Research Communications. 2024-04-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: